Medical Marijuana, Inc. announced that its subsidiary Kannaway® has launched a completely redesigned website and the rebranding of its globally recognized hemp-derived cannabidiol (CBD) products.
The company hopes that consumers will find the new website easier to navigate for access to the products and CBD education that fits their unique lifestyles. Kannaway’s rebranded products are designed to be more relatable to consumers and make it easier for them to incorporate CBD’s benefits into their everyday routines.
“We continue to see a large increase in consumer demand for high-quality CBD products as the U.S. hemp-derived CBD industry is expected to hit $22 billion by 2022,” said Kannaway CEO Blake Schroeder. “In response, we chose to redesign our website and rebrand our products so that consumers can easily educate themselves before discovering which products best fit their needs.”
In Q1 of 2019, Kannaway experienced an increase of approximately 130 percent in sales revenue as compared to Q1 2018.
“As awareness for CBD continues to spread, it is a priority for us to ensure consumers are well educated on the compound and understand how it may enhance their lifestyles,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “Kannaway’s rebranded products not only provide the many benefits of CBD but are also aesthetically pleasing for consumers to use and display in their homes.”